Shanghai Cancer Institute
In research, Shanghai Cancer Institute stands highest in Life Sciences (#705 of 7,800 worldwide), Biochemistry, Genetics and Molecular Biology (#861 of 3,579 worldwide) and Medicine (#2,583 of 10,443 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research, Oncology and Immunology — Cancer Research is 17.7× its share of world research.
- World rank, 2022–2025
- #1,842 of 28,054 · #4,984 all time
- Rank in China
- #505 of 3,058
- Research works
- 1.3k ▲ 56% vs 2013–17
- Citations
- 51k 39.6 per fractional work
- Top-10% rate
- 38.8% record average 16.5%
- Open access
- 52% world 28%
What is Shanghai Cancer Institute known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #705 of 7,800 | 42.3% | 147 | #1871 | |
| Biochemistry, Genetics and Molecular BiologyField | #861 of 3,579 | 40.4% | 111 | #2140 | |
| MedicineField | #2,583 of 10,443 | 34.1% | 152 | #3983 | |
| Health SciencesDomain | #3,194 of 11,982 | 34.0% | 155 | #5248 | |
| Molecular BiologySubfield | #806 of 2,175 | 39.7% | 66 | #1602 |
Each strip is that field’s whole ranked pool, with the notch where Shanghai Cancer Institute sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#1,871 #705
- Biochemistry, Genetics and Molecular Biology#2,140 #861
- Medicine#3,983 #2,583
- Health Sciences#5,248 #3,194
- Molecular Biology#1,602 #806
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Shanghai Cancer Institute specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 17.7× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 25.8 works18×
- OncologySubfield · 45.9 works12×
- ImmunologySubfield · 27.4 works12×
- Immunology and MicrobiologyField · 28.3 works8.4×
- Molecular BiologySubfield · 65.7 works6.5×
- Biochemistry, Genetics and Molecular BiologyField · 110.6 works6.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.4×. Every wedge is a field page.
- Immunology and Microbiology 8.4×
- Biochemistry, Genetics and Molecular Biology 6.2×
- Medicine 2.4×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Chemistry 1.0×
- Nursing 0.9×
- Neuroscience 0.8×
- Materials Science 0.7×
- Dentistry 0.6×
- Chemical Engineering 0.3×
- Physics and Astronomy 0.2×
- Engineering 0.2×
- Environmental Science 0.2×
- Health Professions 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Energy 0.1×
- Psychology 0.1×
- Earth and Planetary Sciences 0.0×
- Economics, Econometrics and Finance 0.0×
- Mathematics 0.0×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Who are the top researchers at Shanghai Cancer Institute?
Ranked on the composite score, Yu‐Tang Gao, Hui Cai and Yong‐Bing Xiang lead among researchers whose main affiliation is Shanghai Cancer Institute.
- 1 Yu‐Tang Gao China · #26,180 worldwide 750 citations · 83 works
- 2 Hui Cai China · #66,951 worldwide 265 citations · 36 works
- 3 Yong‐Bing Xiang China · #117,080 worldwide 231 citations · 49 works
- 4 Honglan Li China · #164,567 worldwide 162 citations · 30 works
- 5 Gong Yang China · #257,563 worldwide 125 citations · 31 works
- 6 Jinjun Li China · #288,804 worldwide 135 citations · 23 works
- 7 Wenxin Qin China · #349,355 worldwide 174 citations · 28 works
- 8 Jianren Gu China · #350,778 worldwide 97 citations · 20 works
- 9 Zonghai Li China · #379,633 worldwide 78 citations · 21 works
- 10 Ming Yao China · #430,723 worldwide 149 citations · 16 works
Which keywords describe research at Shanghai Cancer Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Tumor Microenvironment, Immunotherapy, Inflammation, Chemotherapy, Gene Expression, Immunity and Neoadjuvant Therapy.
- Epigenetic Regulation
- RNA methylation
- Activation
- Gene Expression Regulation
- Reactive Oxygen Species
- Targeted Therapy
- Ferroptosis
- Clinical Practice Guidelines
- PD-1 and PD-L1
- Lipid Peroxidation
- Metastasis
- Surgical Complications
- Pancreatic Cancer
- Cancer Therapy
- Metabolism
- Nanoparticles
- Immunity
- Oxidative Stress
- Inflammation
- Tumor Microenvironment
- Cancer
- Immunotherapy
- Chemotherapy
- Gene Expression
- Neoadjuvant Therapy
- Biomarkers
- Cell Death
- Prognostic Factors
- Gemcitabine
- Cancer Progression
- Tumor Targeting
- Immune Checkpoint Blockade
- Cancer Immunotherapy
- Genetic Mutations
- GPX4
- Regulation
- Innate Immunity
- Macrophage
- Polarization
- m6A-seq
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer51▲ 11×45 topics
- Tumor Microenvironment42▲ 28×8 topics
- Immunotherapy35▲ 15×14 topics
- Inflammation32▲ 4.5×65 topics
- Chemotherapy24▲ 10×18 topics
- Oxidative Stress22▲ 4.0×39 topics
- Gene Expression21▲ 10×11 topics
- Immunity17▲ 13×9 topics
- Neoadjuvant Therapy16▲ 21×5 topics
- Nanoparticles14▲ 3.4×20 topics
- Biomarkers14▲ 6.1×13 topics
- Metabolism14▲ 8.2×24 topics
- Cell Death13▲ 17×6 topics
- Cancer Therapy12▲ 6.5×17 topics
- Prognostic Factors12▲ 8.5×14 topics
- Pancreatic Cancer12▲ 33×3 topics
- Gemcitabine12▲ 48×1 topic
- Surgical Complications12▲ 43×1 topic
- Cancer Progression11▲ 18×8 topics
- Metastasis11▲ 9.7×12 topics
- Tumor Targeting11▲ 18×3 topics
- Lipid Peroxidation10▲ 29×2 topics
- Immune Checkpoint Blockade10▲ 27×1 topic
- PD-1 and PD-L110▲ 27×1 topic
- Cancer Immunotherapy10▲ 19×3 topics
- Clinical Practice Guidelines10▲ 5.4×11 topics
- Genetic Mutations10▲ 6.8×12 topics
- Ferroptosis10▲ 38×1 topic
- GPX410▲ 38×1 topic
- Targeted Therapy10▲ 13×5 topics
- Regulation9▲ 5.2×10 topics
- Reactive Oxygen Species9▲ 6.6×11 topics
- Innate Immunity9▲ 8.1×11 topics
- Gene Expression Regulation8▲ 23×3 topics
- Macrophage8▲ 34×2 topics
- Activation8▲ 40×1 topic
- Polarization8▲ 16×1 topic
- RNA methylation8▲ 27×1 topic
- m6A-seq8▲ 27×1 topic
- Epigenetic Regulation8▲ 10×5 topics
Which research topics does Shanghai Cancer Institute publish most on?
By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis and Immune cells in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pancreatic and Hepatic Oncology Research Oncology 12 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 10 works
- 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 10 works
- 4 Immune cells in cancer Immunology 8 works
- 5 RNA modifications and cancer Molecular Biology 8 works
- 6 Cancer, Hypoxia, and Metabolism Cancer Research 7 works
- 7 Nanoplatforms for cancer theranostics Biomedical Engineering 6 works
- 8 Epigenetics and DNA Methylation Molecular Biology 6 works
- 9 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 5 works
- 10 Cancer Genomics and Diagnostics Cancer Research 5 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Shanghai Cancer Institute's research output changed?
Output in 2018–2022 was 56% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shanghai
- Shanghai Jiao Tong University
- Tongji University
- Fudan University
- Shanghai University
- East China Normal University
- East China University of Science and Technology
- Donghua University
- University of Shanghai for Science and Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.